{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:26:53Z","timestamp":1794551213647,"version":"4.9.1"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11010-022-04587-x","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T11:04:06Z","timestamp":1667041446000},"page":"1307-1324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":245,"title":["Impairment of insulin signaling pathway PI3K\/Akt\/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review"],"prefix":"10.1007","volume":"478","author":[{"given":"Kanagavalli","family":"Ramasubbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Devi Rajeswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"4587_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jep.2016.07.024","volume":"192","author":"B Dai","year":"2016","unstructured":"Dai B, Wu Q, Zeng C, Zhang J, Cao L, Xiao Z, Yang M (2016) The effect of Liuwei Dihuang Decoction on PI3K\/Akt signaling pathway in liver of type 2 Diabetes Mellitus (T2DM) rats with insulin resistance. J Ethnopharmacol 192:382\u2013389. https:\/\/doi.org\/10.1016\/j.jep.2016.07.024","journal-title":"J Ethnopharmacol"},{"key":"4587_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104204","volume":"75","author":"CJ He","year":"2020","unstructured":"He CJ, Ma LQ, Iqbal MS, Huang XJ, Li J, Yang GZ, Ihsan A (2020) Veratrilla Baillonii Franch exerts anti-diabetic activity and improves liver injury through IRS\/PI3K\/AKT signaling pathways in Type 2 Diabetic Db\/Db mice. J Funct Foods 75:104204. https:\/\/doi.org\/10.1016\/j.jff.2020.104204","journal-title":"J Funct Foods"},{"key":"4587_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A (2018) The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3\u03b2 signaling in Parkinson\u2019s disease dementia. Front Neurosci 12:1\u20138. https:\/\/doi.org\/10.3389\/fnins.2018.00073","journal-title":"Front Neurosci"},{"key":"4587_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/aws009","volume":"136","author":"I Aviles-Olmos","year":"2013","unstructured":"Aviles-Olmos I, Limousin P, Lees A, Foltynie T (2013) Parkinson\u2019s Disease, insulin resistance and novel agents of neuroprotection. Brain 136:374\u2013384. https:\/\/doi.org\/10.1093\/brain\/aws009","journal-title":"Brain"},{"key":"4587_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005921","author":"YW Yang","year":"2017","unstructured":"Yang YW, Hsieh TF, Li CI, Liu CS, Lin WY, Chiang JH, Li TC, Lin CC (2017) Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (United States). https:\/\/doi.org\/10.1097\/MD.0000000000005921","journal-title":"Medicine (United States)"},{"key":"4587_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11064-020-03167-z","volume":"46","author":"F Chu","year":"2021","unstructured":"Chu F, Li K, Li X, Xu L, Huang J, Yang Z (2021) Graphene oxide ameliorates the cognitive impairment through inhibiting PI3K\/Akt\/MTOR pathway to induce autophagy in AD mouse model. Neurochem Res 46:309\u2013325. https:\/\/doi.org\/10.1007\/s11064-020-03167-z","journal-title":"Neurochem Res"},{"key":"4587_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2019.00204","volume":"10","author":"P Barbier","year":"2019","unstructured":"Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, Tsvetkov PO, Devred F, Landrieu I (2019) Role of Tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci 10:1\u201314. https:\/\/doi.org\/10.3389\/fnagi.2019.00204","journal-title":"Front Aging Neurosci"},{"key":"4587_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2018.00118","volume":"10","author":"HM Brothers","year":"2018","unstructured":"Brothers HM, Gosztyla ML, Robinson SR (2018) The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer\u2019s Disease. Front Aging Neurosci 10:1\u201316. https:\/\/doi.org\/10.3389\/fnagi.2018.00118","journal-title":"Front Aging Neurosci"},{"key":"4587_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A (2014) Role of advanced glycation end products in cellular signaling. Redox Biol 2:411\u2013429. https:\/\/doi.org\/10.1016\/j.redox.2013.12.016","journal-title":"Redox Biol"},{"key":"4587_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm-20-3768","volume":"8","author":"G Zhao","year":"2020","unstructured":"Zhao G, Zhang X, Wang H, Chen Z (2020) Beta carotene protects H9c2 cardiomyocytes from advanced glycation end product-induced endoplasmic reticulum stress, apoptosis, and autophagy via the PI3K \/ Akt \/ MTOR signaling pathway. Ann Transl Med 8:1\u201313. https:\/\/doi.org\/10.21037\/atm-20-3768","journal-title":"Ann Transl Med"},{"key":"4587_CR11","doi-asserted-by":"publisher","first-page":"101546","DOI":"10.1016\/j.redox.2020.101546","volume":"34","author":"A Sharma","year":"2020","unstructured":"Sharma A, Weber D, Raupbach J, Dakal TC, Flie\u00dfbach K, Ramirez A, Grune T, W\u00fcllner U (2020) Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson\u2019s and Alzheimer\u2019s disease. Redox Biol 34:101546. https:\/\/doi.org\/10.1016\/j.redox.2020.101546","journal-title":"Redox Biol"},{"key":"4587_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-016-0068-5","volume":"11","author":"Y Kim","year":"2016","unstructured":"Kim Y, Kim C, Son SM, Song H, Hong HS, Han SH, Mook-Jung I (2016) The novel RAGE Interactor PRAK is associated with autophagy signaling in Alzheimer\u2019s disease pathogenesis. Mol Neurodegener 11:1\u201311. https:\/\/doi.org\/10.1186\/s13024-016-0068-5","journal-title":"Mol Neurodegener"},{"key":"4587_CR13","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2012-0826","author":"C Adamopoulos","year":"2013","unstructured":"Adamopoulos C, Farmaki E, Spilioti E, Kiaris H, Piperi C (2013) Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2012-0826","journal-title":"Clin Chem Lab Med"},{"key":"4587_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"F Xu","year":"2020","unstructured":"Xu F, Na L, Li Y, Chen L (2020) Roles of the PI3K\/AKT\/MTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 10:1\u201312. https:\/\/doi.org\/10.1186\/s13578-020-00416-0","journal-title":"Cell Biosci"},{"key":"4587_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.phrs.2017.12.026","volume":"130","author":"J Yan","year":"2018","unstructured":"Yan J, Wang C, Jin Y, Meng Q, Liu Q, Liu Z, Liu K, Sun H (2018) Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK\/NOX4\/PI3K\/AKT pathway. Pharmacol Res 130:466\u2013480. https:\/\/doi.org\/10.1016\/j.phrs.2017.12.026","journal-title":"Pharmacol Res"},{"key":"4587_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2019\/4189813","volume":"2019","author":"JM Dos Santos","year":"2019","unstructured":"Dos Santos JM, Tewari S, Mendes RH (2019) The role of oxidative stress in the development of diabetes mellitus and its complications. J Diabetes Res 2019:10\u201312. https:\/\/doi.org\/10.1155\/2019\/4189813","journal-title":"J Diabetes Res"},{"key":"4587_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.cellsig.2016.05.007","volume":"28","author":"J Wang","year":"2016","unstructured":"Wang J, Yang X, Zhang J (2016) Bridges between mitochondrial oxidative stress, ER stress and MTOR signaling in pancreatic \u03b2 cells. Cell Signal 28:1099\u20131104. https:\/\/doi.org\/10.1016\/j.cellsig.2016.05.007","journal-title":"Cell Signal"},{"key":"4587_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cytogfr.2019.03.001","volume":"50","author":"SW Jere","year":"2019","unstructured":"Jere SW, Houreld NN, Abrahamse H (2019) Role of the PI3K\/AKT (MTOR and GSK3\u03b2) signalling pathway and photobiomodulation in diabetic wound healing. Cytokine Growth Factor Rev 50:52\u201359. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.03.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"4587_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mvr.2017.07.002","volume":"114","author":"M Hassanpour","year":"2017","unstructured":"Hassanpour M, Rezabakhsh A, Rahbarghazi R, Nourazarian A, Nouri M, Avci \u00c7B, Ghaderi S, Alidadyani N, Bagca BG, Bagheri HS (2017) Functional convergence of Akt protein with VEGFR-1 in human endothelial progenitor cells exposed to sera from patient with type 2 diabetes mellitus. Microvasc Res 114:101\u2013113. https:\/\/doi.org\/10.1016\/j.mvr.2017.07.002","journal-title":"Microvasc Res"},{"key":"4587_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.arcmed.2020.05.002","volume":"51","author":"S Bathina","year":"2020","unstructured":"Bathina S, Gundala NKV, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, Das UN (2020) Resolvin D1 ameliorates nicotinamide-streptozotocin-induced type 2 diabetes mellitus by its anti-inflammatory action and modulating PI3K\/Akt\/MTOR pathway in the brain. Arch Med Res 51:492\u2013503. https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.002","journal-title":"Arch Med Res"},{"key":"4587_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7069052","author":"Q Di Tu","year":"2020","unstructured":"Di Tu Q, Jin J, Hu X, Ren Y, Zhao L, He Q (2020) Curcumin improves the renal autophagy in rat experimental membranous nephropathy via regulating the PI3K\/AKT\/MTOR and Nrf2\/HO-1 signaling pathways. BioMed Res Int. https:\/\/doi.org\/10.1155\/2020\/7069052","journal-title":"BioMed Res Int"},{"key":"4587_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5947859","author":"R Villalobos-Labra","year":"2017","unstructured":"Villalobos-Labra R, Silva L, Subiabre M, Araos J, Salsoso R, Fuenzalida B, S\u00e1ez T, Toledo F, Gonz\u00e1lez M, Quezada C, Pardo F, Chiarello DI, Leiva A, Sobrevia L (2017) Akt\/MTOR role in human foetoplacental vascular insulin resistance in diseases of pregnancy. J Diabetes Res. https:\/\/doi.org\/10.1155\/2017\/5947859","journal-title":"J Diabetes Res"},{"key":"4587_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-7-14","volume":"7","author":"K Mardilovich","year":"2009","unstructured":"Mardilovich K, Pankratz SL, Shaw LM (2009) Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 7:1\u201315. https:\/\/doi.org\/10.1186\/1478-811X-7-14","journal-title":"Cell Commun Signal"},{"key":"4587_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113306","author":"A Tumminia","year":"2018","unstructured":"Tumminia A, Vinciguerra F, Parisi M, Frittitta L (2018) Type 2 diabetes mellitus and Alzheimer\u2019s disease: role of insulin signalling and therapeutic implications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19113306","journal-title":"Int J Mol Sci"},{"key":"4587_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112863","volume":"257","author":"S Bao","year":"2020","unstructured":"Bao S, Wu YL, Wang X, Han S, Cho SB, Ao W, Nan JX (2020) Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic Db\/Db mice targeting INS-R\/IRS-2\/PI3K\/AKT\/PPAR-\u03b3\/Glut4 signal pathway. J Ethnopharmacol 257:112863. https:\/\/doi.org\/10.1016\/j.jep.2020.112863","journal-title":"J Ethnopharmacol"},{"key":"4587_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2018.03.003","volume":"47","author":"A Rabiee","year":"2018","unstructured":"Rabiee A, Kr\u00fcger M, Ardenkj\u00e6r-Larsen J, Kahn CR, Emanuelli B (2018) Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin\/IGF-1 action. Cell Signal 47:1\u201315. https:\/\/doi.org\/10.1016\/j.cellsig.2018.03.003","journal-title":"Cell Signal"},{"key":"4587_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025.mTOR","volume":"12","author":"R Zoncu","year":"2012","unstructured":"Zoncu R, Efeyan A, Sabatini D (2012) MTOR: from growth signal integration to cancer. Diabetes Ageing. 12:21\u201335. https:\/\/doi.org\/10.1038\/nrm3025.mTOR","journal-title":"Diabetes Ageing."},{"key":"4587_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cmet.2017.03.004","volume":"25","author":"T Kubota","year":"2017","unstructured":"Kubota T, Kubota N, Kadowaki T (2017) Imbalanced insulin actions in obesity and type 2 diabetes\u202f: key mouse models of insulin signaling pathway. Cell Metab 25:797\u2013810. https:\/\/doi.org\/10.1016\/j.cmet.2017.03.004","journal-title":"Cell Metab"},{"key":"4587_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066417","author":"Q Wang","year":"2013","unstructured":"Wang Q, Cheng XL, Zhang DY, Gao XJ, Zhou L, Qin XY, Xie GY, Liu K, Qin Y, Liu BL, Qin MJ (2013) Tectorigenin attenuates palmitate-induced endothelial insulin resistance via targeting ROS-associated inflammation and IRS-1 pathway. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0066417","journal-title":"PLoS One"},{"key":"4587_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cmet.2011.03.022.Insulin","volume":"13","author":"IE Deyev","year":"2012","unstructured":"Deyev IE, Sohet F, Vassilenko KP, Serova OV, Nadezhda V, Zozulya SA, Burova EB, Houillier P, Rzhevsky DI, Berchatova AA, Murashev AN, Chugunov AO, Roman G, Nikol NN, Bertelli E, Eladari D, Alexander G (2012) Insulin receptor-related receptor as an extracellular alkali sensor. Cell Metab. 13:679\u2013689. https:\/\/doi.org\/10.1016\/j.cmet.2011.03.022.Insulin","journal-title":"Cell Metab."},{"key":"4587_CR31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90437.2008","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab. https:\/\/doi.org\/10.1152\/ajpendo.90437.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4587_CR32","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1021\/acs.jafc.6b04682","volume":"65","author":"S Gao","year":"2017","unstructured":"Gao S, Guo Q, Qin C, Shang R, Zhang Z (2017) Sea Buckthorn fruit oil extract alleviates insulin resistance through the PI3K\/Akt signaling pathway in type 2 diabetes mellitus cells and rats. J Agric Food Chem 65:1328\u20131336. https:\/\/doi.org\/10.1021\/acs.jafc.6b04682","journal-title":"J Agric Food Chem"},{"key":"4587_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"C O\u2019Neill","year":"2013","unstructured":"O\u2019Neill C (2013) PI3-Kinase\/Akt\/MTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease. Exp Gerontol 48:647\u2013653. https:\/\/doi.org\/10.1016\/j.exger.2013.02.025","journal-title":"Exp Gerontol"},{"key":"4587_CR34","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0700373104","volume":"104","author":"B Geering","year":"2007","unstructured":"Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B (2007) Class IA phosphoinositide 3-kinases are obligate P85\u2013P110 heterodimers. Proc Natl Acad Sci USA 104:7809\u20137814. https:\/\/doi.org\/10.1073\/pnas.0700373104","journal-title":"Proc Natl Acad Sci USA"},{"key":"4587_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/mmr.2018.9713","volume":"19","author":"Y Xie","year":"2019","unstructured":"Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, Jiang B, Feng J, Li J, Gu Y (2019) PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (review). Mol Med Reports 19:783\u2013791. https:\/\/doi.org\/10.3892\/mmr.2018.9713","journal-title":"Mol Med Reports"},{"key":"4587_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.biopha.2018.06.089","volume":"106","author":"Y Fan","year":"2018","unstructured":"Fan Y, He Z, Wang W, Li J, Hu A, Li L, Yan L, Li Z, Yin Q (2018) Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS\/PI3K\/AKT signaling pathway. Biomed Pharmacother 106:733\u2013737. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.089","journal-title":"Biomed Pharmacother"},{"key":"4587_CR37","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1128\/MCB.25.5.1596","volume":"25","author":"SM Brachmann","year":"2005","unstructured":"Brachmann SM, Ueki K, Engelman JA, Kahn RC, Cantley LC (2005) Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Exp Gerontol 25:1596\u20131607. https:\/\/doi.org\/10.1128\/MCB.25.5.1596","journal-title":"Exp Gerontol"},{"key":"4587_CR38","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E12-05-0337","author":"A Gupta","year":"2009","unstructured":"Gupta A, Dey CS, Chernoff J (2009) PTEN, a widely known negative regulator of insulin \/ PI3K signaling Positively Regulates Neuronal Insulin Resistance. Mol Biol Cell. https:\/\/doi.org\/10.1091\/mbc.E12-05-0337","journal-title":"Mol Biol Cell"},{"key":"4587_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002.Regulation","volume":"25","author":"CC Dibble","year":"2015","unstructured":"Dibble CC, Cantely LC (2015) Regulation of MTORC1 by PI3K signaling. Trends Cell Biol 25:545\u2013555. https:\/\/doi.org\/10.1016\/j.tcb.2015.06.002.Regulation","journal-title":"Trends Cell Biol"},{"key":"4587_CR40","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1039\/c5mb00101c","volume":"11","author":"T Ersahin","year":"2015","unstructured":"Ersahin T, Tuncbag N, Cetin-Atalay R (2015) The PI3K\/AKT\/MTOR interactive pathway. Mol BioSyst 11:1946\u20131954. https:\/\/doi.org\/10.1039\/c5mb00101c","journal-title":"Mol BioSyst"},{"key":"4587_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-018-0809-2","volume":"17","author":"S Bathina","year":"2018","unstructured":"Bathina S, Das UN (2018) Dysregulation of PI3K-Akt-MTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in Wistar rats. Lipids Health Dis 17:1\u201311. https:\/\/doi.org\/10.1186\/s12944-018-0809-2","journal-title":"Lipids Health Dis"},{"key":"4587_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/ATVBAHA.117.309819.Akt2","volume":"38","author":"V Sudhahar","year":"2019","unstructured":"Sudhahar V, Okur MN, Bagi Z, Bryan JPO, Hay N, Makino A, Patel VS, Phillips SA, Stepp D, Fukai T, Genetics M, Veterans B, Medical A, Veterans N, Medical A (2019) Akt2 stabilizes ATP7A, a Cu transporter for SOD3, in vascular smooth muscles: novel mechanism to limit endothelial dysfunction in Type2 diabetes. Arterioscler Thromb Vasc Biol. 38:529\u2013541. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309819.Akt2","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"4587_CR43","doi-asserted-by":"publisher","unstructured":"Furlong RM (2019) The Parkinson\u2019s gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI(3,4,5) P3. J Cell Sci 3:132. https:\/\/doi.org\/10.1242\/jcs.233221","DOI":"10.1242\/jcs.233221"},{"key":"4587_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2019.00531","volume":"10","author":"C Bian","year":"2019","unstructured":"Bian C, Bai B, Gao Q, Li S, Zhao Y (2019) 17\u03b2-estradiol regulates glucose metabolism and insulin secretion in rat islet \u03b2 cells through GPER and Akt\/MTOR\/GLUT2 pathway. Front Endocrinol 10:1\u201312. https:\/\/doi.org\/10.3389\/fendo.2019.00531","journal-title":"Front Endocrinol"},{"key":"4587_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-170440","volume":"60","author":"R Karki","year":"2017","unstructured":"Karki R, Tom A, Hofmann-Apitius M (2017) Comorbidity analysis between Alzheimer\u2019s disease and type 2 diabetes mellitus ( T2DM ) based on shared pathways and the role of T2DM drugs. J Alzheimers Dis 60:721\u2013731. https:\/\/doi.org\/10.3233\/JAD-170440","journal-title":"J Alzheimers Dis"},{"key":"4587_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112479","author":"B Tuohetaerbaike","year":"2020","unstructured":"Tuohetaerbaike B, Zhang Y, Tian Y, nan Zhang N, Kang J, Mao X, Zhang Y, Li X (2020) Pancreas protective effects of urolithin a on type 2 diabetic mice induced by high fat and streptozotocin via regulating autophagy and AKT\/MTOR signaling pathway. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2019.112479","journal-title":"J Ethnopharmacol"},{"key":"4587_CR47","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN, Dilnashin H, Birla H, Singh S. Sen, Zahra W, Rathore AS, Singh BK, Singh SP (2019) The role of PI3K\/Akt and ERK in neurodegenerative disorders. Neurotox Res 35:775\u2013795. https:\/\/doi.org\/10.1007\/s12640-019-0003-y","journal-title":"Neurotox Res"},{"key":"4587_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.06.043","author":"Y Wang","year":"2016","unstructured":"Wang Y, Duan W, Wang W, Wen D, Liu Y, Liu Y, Li Z, Hu H, Lin H, Cui C, Li D, Dong H (2016) ScAAV9-VEGF prolongs the survival of transgenic ALS mice by promoting activation of M2 microglia and the PI3K\/Akt pathway. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2016.06.043","journal-title":"Brain Res"},{"key":"4587_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/JLB.3MR0317-095RR","volume":"106","author":"Y Tuo","year":"2019","unstructured":"Tuo Y, Xiang M (2019) MTOR: a double-edged sword for diabetes. J Leukocyte Biol 106:385\u2013395. https:\/\/doi.org\/10.1002\/JLB.3MR0317-095RR","journal-title":"J Leukocyte Biol"},{"key":"4587_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/384683","volume":"2009","author":"A Katta","year":"2009","unstructured":"Katta A, Kakarla S, Wu M, Paturi S, Gadde MK, Arvapalli R, Kolli M, Rice KM, Blough ER (2009) Altered regulation of contraction-induced Akt\/MTOR\/P70S6k pathway signaling in skeletal muscle of the Obese Zucker Rat. Exp Diabetes Res 2009:384683. https:\/\/doi.org\/10.1155\/2009\/384683","journal-title":"Exp Diabetes Res"},{"key":"4587_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbi.2018.02.011","volume":"284","author":"P Muthukumaran","year":"2018","unstructured":"Muthukumaran P, Thiyagarajan G, Arun Babu R, Lakshmi BS (2018) Raffinose from Costus speciosus attenuates lipid synthesis through modulation of PPARs\/SREBP1c and improves insulin sensitivity through PI3K\/AKT. Chemico-Biol Interact 284:80\u201389. https:\/\/doi.org\/10.1016\/j.cbi.2018.02.011","journal-title":"Chemico-Biol Interact"},{"key":"4587_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/hep.31310","volume":"73","author":"X Lu","year":"2021","unstructured":"Lu X, Paliogiannis P, Calvisi DF, Chen X (2021) Role of the mammalian target of rapamycin pathway in liver cancer: from molecular genetics to targeted therapies. Hepatology 73:49\u201361. https:\/\/doi.org\/10.1002\/hep.31310","journal-title":"Hepatology"},{"key":"4587_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2020.101481","volume":"69","author":"G Zheng","year":"2021","unstructured":"Zheng G, Wang L, Li X, Niu X, Xu G, Lv P (2021) Rapamycin alleviates cognitive impairment in murine vascular dementia: the enhancement of mitophagy by PI3K\/AKT\/MTOR axis. Tissue Cell 69:101481. https:\/\/doi.org\/10.1016\/j.tice.2020.101481","journal-title":"Tissue Cell"},{"key":"4587_CR54","first-page":"1","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials 06 biological sciences 0601 biochemistry and cell biology. Mol Cancer 18:1\u201328","journal-title":"Mol Cancer"},{"key":"4587_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2640342","author":"A Kezic","year":"2018","unstructured":"Kezic A, Popovic L, Lalic K (2018) MTOR inhibitor therapy and metabolic consequences: where do we stand? Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/2640342","journal-title":"Oxid Med Cell Longev"},{"key":"4587_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13679-020-00396-9","volume":"9","author":"C Koliaki","year":"2020","unstructured":"Koliaki C, Liatis S, Dalamaga M, Kokkinos A (2020) the implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obesity Reports 9:255\u2013271. https:\/\/doi.org\/10.1007\/s13679-020-00396-9","journal-title":"Curr Obesity Reports"},{"key":"4587_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2036.2005.02599.x","volume":"22","author":"G Wilcox","year":"2005","unstructured":"Wilcox G (2005) Insulin and insulin resistance. Aliment Pharmacol Ther Suppl 22:61\u201363. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02599.x","journal-title":"Aliment Pharmacol Ther Suppl"},{"key":"4587_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2515690X18790725","volume":"23","author":"CT Peterson","year":"2018","unstructured":"Peterson CT, Vaughn AR, Sharma V, Chopra D, Mills PJ, Peterson SN, Sivamani RK (2018) Effects of turmeric and curcumin dietary supplementation on human gut microbiota: a double-blind, randomized, placebo-controlled pilot study. J Evid Based Integr Med 23:1\u20138. https:\/\/doi.org\/10.1177\/2515690X18790725","journal-title":"J Evid Based Integr Med"},{"key":"4587_CR59","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s12035-019-01824-1.Manganese","volume":"57","author":"MR Bryan","year":"2021","unstructured":"Bryan MR, Nordham KD, Rose DIR, Joshi P, Foshage AM, Nitin R, Michael A, Aschner M, Bowman AB, Lafayette W (2021) Manganese acts upon insulin\/IGF receptors to phosphorylate AKT and increase glucose uptake in Huntington\u2019s disease cells. Mol Neurobiol 57:1570\u20131593. https:\/\/doi.org\/10.1007\/s12035-019-01824-1.Manganese","journal-title":"Mol Neurobiol"},{"key":"4587_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00060793-200002000-00001","volume":"7","author":"V Aguirre","year":"2000","unstructured":"Aguirre V, White MF (2000) Dysregulation of IRS-proteins causes insulin resistance and diabetes. Current Opin Endocrinol Diabetes 7:1\u20137. https:\/\/doi.org\/10.1097\/00060793-200002000-00001","journal-title":"Current Opin Endocrinol Diabetes"},{"key":"4587_CR61","doi-asserted-by":"publisher","first-page":"118713","DOI":"10.1016\/j.lfs.2020.118713","volume":"263","author":"L Gao","year":"2020","unstructured":"Gao L, Yuan P, Zhang Q, Fu Y, Hou Y, Wei Y, Zheng X, Feng W (2020) Taxifolin improves disorders of glucose metabolism and water-salt metabolism in kidney via PI3K\/AKT signaling pathway in metabolic syndrome rats. Life Sci 263:118713. https:\/\/doi.org\/10.1016\/j.lfs.2020.118713","journal-title":"Life Sci"},{"key":"4587_CR62","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"4587_CR63","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI (2012) Review mechanisms for insulin resistance: common threads and missing links. Cell 148:852\u2013871. https:\/\/doi.org\/10.1016\/j.cell.2012.02.017","journal-title":"Cell"},{"key":"4587_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","volume":"293","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M (2010) Case-control study of risk of Parkinson\u2019s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan. J Neurol Sci 293:82\u201386. https:\/\/doi.org\/10.1016\/j.jns.2010.03.002","journal-title":"J Neurol Sci"},{"key":"4587_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111750","volume":"140","author":"Q Song","year":"2021","unstructured":"Song Q, Liu J, Dong L, Wang X, Zhang X (2021) Novel advances in inhibiting advanced glycation end product formation using natural compounds. Biomed Pharmacother 140:111750. https:\/\/doi.org\/10.1016\/j.biopha.2021.111750","journal-title":"Biomed Pharmacother"},{"key":"4587_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jdiacomp.2015.12.018","volume":"30","author":"CP Domingueti","year":"2016","unstructured":"Domingueti CP, Dusse LMSA, Carvalho MDG, De Sousa LP, Gomes KB, Fernandes AP (2016) Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat 30:738\u2013745. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.12.018","journal-title":"J Diabetes Complicat"},{"key":"4587_CR67","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1096\/fj.201903223RR","volume":"34","author":"N Horii","year":"2020","unstructured":"Horii N, Hasegawa N, Fujie S, Uchida M, Iemitsu M (2020) Resistance exercise-induced increase in muscle 5\u03b1-dihydrotestosterone contributes to the activation of muscle Akt\/MTOR\/P70S6K- and Akt\/AS160\/GLUT4-signaling pathways in type 2 diabetic rats. FASEB J 34:11047\u201311057. https:\/\/doi.org\/10.1096\/fj.201903223RR","journal-title":"FASEB J"},{"key":"4587_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/nu10010051","author":"J Choi","year":"2018","unstructured":"Choi J, Kim KJ, Koh EJ, Lee BY (2018) Gelidium elegans extract ameliorates type 2 diabetes via regulation of MAPK and PI3K\/Akt signaling. Nutrients. https:\/\/doi.org\/10.3390\/nu10010051","journal-title":"Nutrients"},{"key":"4587_CR69","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.freeradbiomed.2009.08.014","volume":"47","author":"TL Archuleta","year":"2009","unstructured":"Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, Lindborg KA, Kim JS, Henriksen EJ (2009) Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of P38 MAPK. Free Radic Biol Med 47:1486\u20131493. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.08.014","journal-title":"Free Radic Biol Med"},{"key":"4587_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1172\/JCI7917","volume":"105","author":"Y Kido","year":"2000","unstructured":"Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. Journal of Clinical Investigation 105:199\u2013205. https:\/\/doi.org\/10.1172\/JCI7917","journal-title":"Journal of Clinical Investigation"},{"key":"4587_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2543-3","volume":"19","author":"Z Yang","year":"2019","unstructured":"Yang Z, Zhang L, Liu J, Lu F, Wang L, Chen Y, Li D (2019) Hypoglycemic effects of Esculeoside A are mediated via activation of AMPK and upregulation of IRS-1. BMC Complement Altern Med 19:1\u20139. https:\/\/doi.org\/10.1186\/s12906-019-2543-3","journal-title":"BMC Complement Altern Med"},{"key":"4587_CR72","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00514.2001","author":"MF White","year":"2002","unstructured":"White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab. https:\/\/doi.org\/10.1152\/ajpendo.00514.2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4587_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-021-02738-3","volume":"11","author":"M Zheng","year":"2021","unstructured":"Zheng M, Wang P (2021) Role of insulin receptor substance - 1 modulating PI3K \/ Akt insulin signaling pathway in Alzheimer\u2019s Disease. 3 Biotech 11:1\u201317. https:\/\/doi.org\/10.1007\/s13205-021-02738-3","journal-title":"3 Biotech"},{"key":"4587_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020399","author":"P Maiti","year":"2019","unstructured":"Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar GL (2019) Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt\/MTOR pathway in cultured glioblastoma cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20020399","journal-title":"Int J Mol Sci"},{"key":"4587_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.00830","volume":"12","author":"LSS Ferreira","year":"2018","unstructured":"Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018) Insulin resistance in Alzheimer\u2019s disease. Front Neurosci 12:1\u201311. https:\/\/doi.org\/10.3389\/fnins.2018.00830","journal-title":"Front Neurosci"},{"key":"4587_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, Gugliucci A, Kapahi P (2018) The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab 28:337\u2013352. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.014","journal-title":"Cell Metab"},{"key":"4587_CR77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2478\/s11658-014-0205-5","volume":"19","author":"P Salahuddin","year":"2014","unstructured":"Salahuddin P, Rabbani G, Khan RH (2014) The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. Cell Mol Biol Lett 19:407\u2013437. https:\/\/doi.org\/10.2478\/s11658-014-0205-5","journal-title":"Cell Mol Biol Lett"},{"key":"4587_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","volume":"317","author":"J Li","year":"2012","unstructured":"Li J, Liu D, Sun L, Lu Y, Zhang Z (2012) Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 317:1\u20135. https:\/\/doi.org\/10.1016\/j.jns.2012.02.018","journal-title":"J Neurol Sci"},{"key":"4587_CR79","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/pro.3425","volume":"27","author":"A Abedini","year":"2018","unstructured":"Abedini A, Derk J, Schmidt AM (2018) The Receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: establishing and exploiting common ground for novel amyloidosis therapies. Protein Sci 27:1166\u20131180. https:\/\/doi.org\/10.1002\/pro.3425","journal-title":"Protein Sci"},{"key":"4587_CR80","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s13311-020-00917-3","volume":"18","author":"VV Giridharan","year":"2021","unstructured":"Giridharan VV, Generoso JS, Collodel A, Dominguini D, Faller CJ, Tardin F, Bhatti GS, Petronilho F, Dal-Pizzol F, Barichello T (2021) Receptor for advanced glycation end products (RAGE) mediates cognitive impairment triggered by pneumococcal meningitis. Neurotherapeutics 18:640\u2013653. https:\/\/doi.org\/10.1007\/s13311-020-00917-3","journal-title":"Neurotherapeutics"},{"key":"4587_CR81","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00350.2007","author":"W Cai","year":"2008","unstructured":"Cai W, He JC, Zhu L, Chen X, Striker GE, Vlassara H (2008) AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of P66shc-dependent FKHRL1 phosphorylation. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00350.2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"4587_CR82","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/ijmm.2012.891","volume":"29","author":"P Hu","year":"2012","unstructured":"Hu P, Lai D, Lu P, Gao J, He H (2012) ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int J Mol Med 29:613\u2013618. https:\/\/doi.org\/10.3892\/ijmm.2012.891","journal-title":"Int J Mol Med"},{"key":"4587_CR83","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1523\/JNEUROSCI.2506-18.2019","volume":"39","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Guo DH, Hernandez CM, Stranahan AM (2019) Endothelial Adora2a activation promotes blood-brain barrier breakdown and cognitive impairment in mice with diet-induced insulin resistance. J Neurosci 39:4179\u20134192. https:\/\/doi.org\/10.1523\/JNEUROSCI.2506-18.2019","journal-title":"J Neurosci"},{"key":"4587_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4981814","author":"Y Sun","year":"2020","unstructured":"Sun Y, Ma C, Sun H, Wang H, Peng W, Zhou Z, Wang H, Pi C, Shi Y, He X (2020) Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/4981814","journal-title":"J Diabetes Res"},{"key":"4587_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP (2020) Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer\u2019s disease. Neurochemistry International 135:104707. https:\/\/doi.org\/10.1016\/j.neuint.2020.104707","journal-title":"Neurochemistry International"},{"key":"4587_CR86","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Morishita R (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A\u03b2 deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA 107:7036\u20137041. https:\/\/doi.org\/10.1073\/pnas.1000645107","journal-title":"Proc Natl Acad Sci USA"},{"key":"4587_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009052","author":"L Chen","year":"2010","unstructured":"Chen L, Wei Y, Wang X, He R (2010) Ribosylation rapidly induces \u03b1 -synuclein to form highly cytotoxic molten globules of advanced glycation end products. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0009052","journal-title":"PLoS One"},{"key":"4587_CR88","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","volume":"63","author":"ET Reyes","year":"1984","unstructured":"Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV (1984) Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci 63:317\u2013324. https:\/\/doi.org\/10.1016\/0022-510X(84)90154-0","journal-title":"J Neurol Sci"},{"key":"4587_CR89","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","volume":"91","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT (2018) Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study. Neurology 91:e139\u2013e142. https:\/\/doi.org\/10.1212\/WNL.0000000000005771","journal-title":"Neurology"},{"key":"4587_CR90","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.parkreldis.2020.10.013","volume":"80","author":"A Delamarre","year":"2020","unstructured":"Delamarre A, Rigalleau V, Meissner WG (2020) Insulin resistance, diabetes and Parkinson\u2019s disease: the match continues. Parkinsonism Relat Disord 80:199\u2013200. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.10.013","journal-title":"Parkinsonism Relat Disord"},{"key":"4587_CR91","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2013.01.016","volume":"19","author":"V Kotagal","year":"2013","unstructured":"Kotagal V, Albin RL, M\u00fcller MLTM, Koeppe RA, Frey KA, Bohnen NI (2013) Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 19:522\u2013526. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.016","journal-title":"Parkinsonism Relat Disord"},{"key":"4587_CR92","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/brain\/awaa262","volume":"143","author":"R Brauer","year":"2020","unstructured":"Brauer R, Wei L, Ma T, Athauda D, Girges C, Vijiaratnam N, Auld G, Whittlesea C, Wong I, Foltynie T (2020) Diabetes medications and risk of Parkinson\u2019s disease: a cohort study of patients with diabetes. Brain 143:3067\u20133076. https:\/\/doi.org\/10.1093\/brain\/awaa262","journal-title":"Brain"},{"key":"4587_CR93","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc10-1333","volume":"34","author":"E Schernhammer","year":"2011","unstructured":"Schernhammer E, Hansen J, Rugbjerg K, Wermuth L, Ritz B (2011) Diabetes and the risk of developing Parkinson\u2019s disease in Denmark. Diabetes Care 34:1102\u20131108. https:\/\/doi.org\/10.2337\/dc10-1333","journal-title":"Diabetes Care"},{"key":"4587_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/nu11061225","author":"K Chen","year":"2019","unstructured":"Chen K, Xie K, Liu Z, Nakasone Y, Sakao K, Hossain A, Hou DX (2019) Preventive effects and mechanisms of garlic on dyslipidemia and gut microbiome dysbiosis. Nutrients. https:\/\/doi.org\/10.3390\/nu11061225","journal-title":"Nutrients"},{"key":"4587_CR95","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/dme.13114","volume":"34","author":"V Gagnum","year":"2017","unstructured":"Gagnum V, Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, Nj\u00f8lstad PR, Skrivarhaug T (2017) Causes of death in childhood-onset type 1 diabetes: long-term follow-up. Diabetic Med 34:56\u201363. https:\/\/doi.org\/10.1111\/dme.13114","journal-title":"Diabetic Med"},{"key":"4587_CR96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.diabres.2017.04.002","volume":"128","author":"X Yin","year":"2017","unstructured":"Yin X, Xu Z, Zhang Z, Li L, Pan Q, Zheng F, Li H (2017) Association of PI3K\/AKT\/MTOR pathway genetic variants with type 2 diabetes mellitus in Chinese. Diabetes Res Clin Pract 128:127\u2013135. https:\/\/doi.org\/10.1016\/j.diabres.2017.04.002","journal-title":"Diabetes Res Clin Pract"},{"key":"4587_CR97","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"key":"4587_CR98","doi-asserted-by":"publisher","first-page":"13051","DOI":"10.1021\/acs.jafc.9b04931","volume":"67","author":"Y Li","year":"2019","unstructured":"Li Y, Liu Y, Liang J, Wang T, Sun M, Zhang Z (2019) Gymnemic acid ameliorates hyperglycemia through PI3K\/AKT- and AMPK-Mediated signaling pathways in type 2 diabetes mellitus rats. J Agric Food Chem 67:13051\u201313060. https:\/\/doi.org\/10.1021\/acs.jafc.9b04931","journal-title":"J Agric Food Chem"},{"key":"4587_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.11.017","author":"AI Walter-h\u00f6liner","year":"2017","unstructured":"Walter-h\u00f6liner AI, Barbarini DS, L\u00fctschg J, Zanier U, Saely CH, Simma B (2017) High prevalence and incidence of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus: results from a 5-year prospective cohort study. Pediatric Neurol. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.11.017","journal-title":"Pediatric Neurol"},{"key":"4587_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.3178","volume":"35","author":"D Kallinikou","year":"2019","unstructured":"Kallinikou D, Soldatou A, Tsentidis C, Louraki M, Kanaka-Gantenbein C, Kanavakis E, Karavanaki K (2019) Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: diagnosis, pathogenesis, and associated genetic markers. Diabetes\/Metab Res Rev 35:1\u201314. https:\/\/doi.org\/10.1002\/dmrr.3178","journal-title":"Diabetes\/Metab Res Rev"},{"key":"4587_CR101","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jphp.13157","volume":"71","author":"J Dong","year":"2019","unstructured":"Dong J, Li H, Bai Y, Wu C (2019) Muscone ameliorates diabetic peripheral neuropathy through activating AKT\/MTOR signalling pathway. J Pharm Pharmacol 71:1706\u20131713. https:\/\/doi.org\/10.1111\/jphp.13157","journal-title":"J Pharm Pharmacol"},{"key":"4587_CR102","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000001461","author":"K Liu","year":"2020","unstructured":"Liu K, Yang Y, Zhou F, Xiao Y, Shi L (2020) Inhibition of PI3K\/AKT\/MTOR signaling pathway promotes autophagy and relieves hyperalgesia in diabetic rats. NeuroReport. https:\/\/doi.org\/10.1097\/WNR.0000000000001461","journal-title":"NeuroReport"},{"key":"4587_CR103","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1007\/s12035-018-1025-9","volume":"55","author":"A Biosa","year":"2018","unstructured":"Biosa A, Outeiro TF, Bubacco L, Bisaglia M (2018) Diabetes mellitus as a risk factor for Parkinson\u2019s disease: a molecular point of view. Mol Neurobiol 55:8754\u20138763. https:\/\/doi.org\/10.1007\/s12035-018-1025-9","journal-title":"Mol Neurobiol"},{"key":"4587_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4650906","author":"JR Gao","year":"2019","unstructured":"Gao JR, Qin XJ, Fang ZH, Li-Shan, Han LP, Hui-Jian Guo MF, Jiang NN (2019) To explore the pathogenesis of vascular lesion of type 2 diabetes mellitus based on the PI3K\/Akt signaling pathway. J Diabetes Res. https:\/\/doi.org\/10.1155\/2019\/4650906","journal-title":"J Diabetes Res"},{"key":"4587_CR105","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gendis.2018.06.001","volume":"5","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang K, Wan W, Cheng Y, Pu X, Ye X (2018) Resveratrol provides neuroprotection by regulating the JAK2\/STAT3\/PI3K\/AKT\/MTOR pathway after stroke in rats. Genes Dis 5:245\u2013255. https:\/\/doi.org\/10.1016\/j.gendis.2018.06.001","journal-title":"Genes Dis"},{"key":"4587_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.08.006","volume":"79","author":"C Du","year":"2016","unstructured":"Du C, Wu M, Liu H, Ren Y, Du Y, Wu H, Wei J, Liu C, Yao F, Wang H, Zhu Y, Duan H, Shi Y (2016) Thioredoxin-interacting protein regulates lipid metabolism via Akt\/MTOR pathway in diabetic kidney disease. Int J Biochem Cell Biol 79:1\u201313. https:\/\/doi.org\/10.1016\/j.biocel.2016.08.006","journal-title":"Int J Biochem Cell Biol"},{"key":"4587_CR107","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3892\/mmr.2018.9749","volume":"19","author":"Z Ran","year":"2019","unstructured":"Ran Z, Zhang Y, Wen X, Ma J (2019) Curcumin inhibits high glucose-induced inflammatory injury in human retinal pigment epithelial cells through the ROS-PI3K\/AKT\/MTOR signaling pathway. Mol Med Reports 19:1024\u20131031. https:\/\/doi.org\/10.3892\/mmr.2018.9749","journal-title":"Mol Med Reports"},{"key":"4587_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP (2020) Neurochemistry international insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer\u2019s disease. Neurochem Int 135:104707. https:\/\/doi.org\/10.1016\/j.neuint.2020.104707","journal-title":"Neurochem Int"},{"key":"4587_CR109","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/S0007114511000316","volume":"106","author":"P Brasny\u00f3","year":"2011","unstructured":"Brasny\u00f3 P, Moln\u00e1r GA, Moh\u00e1s M, Mark\u00f3 L, Laczy B, Cseh J, Mikol\u00e1s E, Szij\u00e1rt\u00f3 IA, M\u00e9rei \u00c1, Halmai R, M\u00e9sz\u00e1ros LG, S\u00fcmegi B, Wittmann I (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in Type 2 diabetic patients. Br J Nutr 106:383\u2013389. https:\/\/doi.org\/10.1017\/S0007114511000316","journal-title":"Br J Nutr"},{"key":"4587_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103082","author":"H Chi","year":"2018","unstructured":"Chi H, Chang H, Sang T (2018) Neuronal cell death mechanisms in major neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19103082","journal-title":"Int J Mol Sci"},{"key":"4587_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2015.00485","volume":"9","author":"JK Juranek","year":"2015","unstructured":"Juranek JK, Daffu GK, Wojtkiewicz J, Lacomis D, Kofler J, Schmidt AM (2015) Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis. Front Cell Neurosci 9:1\u201312. https:\/\/doi.org\/10.3389\/fncel.2015.00485","journal-title":"Front Cell Neurosci"},{"key":"4587_CR112","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2015.12.006","volume":"62","author":"R Ray","year":"2016","unstructured":"Ray R, Juranek JK, Rai V (2016) RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neurosci Biobehav Rev 62:48\u201355. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.12.006","journal-title":"Neurosci Biobehav Rev"},{"key":"4587_CR113","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Hern\u00e1ndez-Dami\u00e1n J, Pedraza-Chaverri J (2014) The role of PI3K\/AKT\/MTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 26:2694\u20132701. https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.019","journal-title":"Cell Signal"},{"key":"4587_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153664","volume":"91","author":"S Fakhri","year":"2021","unstructured":"Fakhri S, Iranpanah A, Mehdi M, Zachariah S (2021) Phytomedicine natural products attenuate PI3K \/ Akt \/ MTOR signaling pathway: a promising strategy in regulating neurodegeneration. Phytomedicine 91:153664. https:\/\/doi.org\/10.1016\/j.phymed.2021.153664","journal-title":"Phytomedicine"},{"key":"4587_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26949-6","volume":"8","author":"MPM Soutar","year":"2018","unstructured":"Soutar MPM, Kempthorne L, Miyakawa S, Annuario E, Melandri D, Harley J, O\u2019Sullivan GA, Wray S, Hancock DC, Cookson MR, Downward J, Carlton M, Plun-Favreau H (2018) AKT signalling selectively regulates PINK1 mitophagy in SHSY5Y cells and human IPSC-derived neurons. Sci Reports 8:1\u201311. https:\/\/doi.org\/10.1038\/s41598-018-26949-6","journal-title":"Sci Reports"},{"key":"4587_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21093165","volume":"21","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Van Giau V (2020) Type 3 diabetes and its role implications in Alzheimer\u2019s disease. Int J Mol Sci 21:1\u201316. https:\/\/doi.org\/10.3390\/ijms21093165","journal-title":"Int J Mol Sci"},{"key":"4587_CR117","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"J Bendor","year":"2014","unstructured":"Bendor J, Logan T, Edwards RH (2014) The function of \u03b1 -synuclein. Neuron 79:1044\u20131066. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004","journal-title":"Neuron"},{"key":"4587_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.56371","volume":"9","author":"J Bruy\u00e8re","year":"2020","unstructured":"Bruy\u00e8re J, Abada YS, Vitet H, Fontaine G, Deloulme JC, C\u00e8s A, Denarier E, Pernet-Gallay K, Andrieux A, Humbert S, Potier MC, Delatour B, Saudou F (2020) Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin. elife 9:1\u201330. https:\/\/doi.org\/10.7554\/eLife.56371","journal-title":"elife"},{"key":"4587_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2017.08.003","volume":"111","author":"SS Singh","year":"2018","unstructured":"Singh SS, Jois SD (2018) Homo- and heterodimerization of proteins in cell signaling: inhibition and drug design. Adv Protein Chem Struct Biol 111:1\u201359","journal-title":"Adv Protein Chem Struct Biol"},{"key":"4587_CR120","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12031-015-0622-6","volume":"57","author":"R Ghasemi","year":"2015","unstructured":"Ghasemi R, Moosavi M, Zarifkar A, RastegarMaghsoudi KN (2015) The interplay of Akt and ERK in A\u03b2 toxicity and insulin-mediated protection in primary hippocampal cell culture. J Mol Neurosci 57:325\u2013334. https:\/\/doi.org\/10.1007\/s12031-015-0622-6","journal-title":"J Mol Neurosci"},{"key":"4587_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.00681","volume":"12","author":"AV Kamynina","year":"2018","unstructured":"Kamynina AV, Esteras N, Koroev DO, Bobkova NV, Balasanyants SM, Simonyan RA, Avetisyan AV, Abramov AY, Volpina OM, Walker DG (2018) Synthetic fragments of receptor for advanced glycation end products bind beta-amyloid 1\u201340 and protect primary brain cells from beta-amyloid toxicity. Front Neurosci 12:1\u20139. https:\/\/doi.org\/10.3389\/fnins.2018.00681","journal-title":"Front Neurosci"},{"key":"4587_CR122","doi-asserted-by":"publisher","first-page":"238485","DOI":"10.1155\/2014\/238485","volume":"2014","author":"C Angeloni","year":"2014","unstructured":"Angeloni C, Zambonin L, Hrelia S (2014) Role of methylglyoxal in Alzheimer\u2019s disease. Biomed Res Int 2014:238485","journal-title":"Biomed Res Int"},{"key":"4587_CR123","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jnc.15096","volume":"158","author":"F Zeng","year":"2021","unstructured":"Zeng F, Liu Y, Huang W, Qing H, Kadowaki T, Kashiwazaki H, Ni J, Wu Z (2021) Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid \u03b2 accumulation after porphyromonas gingivalis infection. J Neurochem 158:724\u2013736. https:\/\/doi.org\/10.1111\/jnc.15096","journal-title":"J Neurochem"},{"key":"4587_CR124","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","volume":"82","author":"W Westwoo","year":"2014","unstructured":"Westwoo W, Beiser A, DeCarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, Wolf PA, Vasan RS, Seshadri S (2014) Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 82:1613\u20131619. https:\/\/doi.org\/10.1212\/WNL.0000000000000382","journal-title":"Neurology"},{"key":"4587_CR125","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.3390\/ijms22189987","volume":"22","author":"A Sedzikowska","year":"2021","unstructured":"Sedzikowska A, Szablewski L (2021) Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci 22:9987","journal-title":"Int J Mol Sci"},{"key":"4587_CR126","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1007\/s12035-019-1475-8","volume":"56","author":"M Su","year":"2019","unstructured":"Su M, Naderi K, Samson N, Youssef I, F\u00fcl\u00f6p L, Bozso Z, Laroche S, Delatour B, Davis S (2019) Mechanisms associated with type 2 diabetes as a risk factor for Alzheimer-related pathology. Mol Neurobiol 56:5815\u20135834. https:\/\/doi.org\/10.1007\/s12035-019-1475-8","journal-title":"Mol Neurobiol"},{"key":"4587_CR127","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-161029","volume":"56","author":"H-K Lee","year":"2016","unstructured":"Lee H-K, Kwon B, Lemere CA, de la Monte S, Itamura K, Ha AY, Querfurth HW (2016) MTORC2 (Rictor) in Alzheimer\u2019s disease and reversal of amyloid- \u03b2 expression-induced insulin resistance and toxicity in rat primary cortical neurons. J Alzheimers Dis 56:1015\u20131036","journal-title":"J Alzheimers Dis"},{"key":"4587_CR128","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/fnl.12.72","volume":"7","author":"ZZ Chong","year":"2012","unstructured":"Chong ZZ, Shang YC, Wang S, Maiese K (2012) A critical kinase cascade in neurological disorders: PI3K, Akt and MTOR. Future Neurol 7:733\u2013748. https:\/\/doi.org\/10.2217\/fnl.12.72","journal-title":"Future Neurol"},{"key":"4587_CR129","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun E, Motolani A, Campos L, Lu T (2022) The pivotal role of NF-KB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci 23:8972. https:\/\/doi.org\/10.3390\/ijms23168972","journal-title":"Int J Mol Sci"},{"key":"4587_CR130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jpi.12238","volume":"59","author":"T Ali","year":"2015","unstructured":"Ali T, Kim MO (2015) Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3\/Akt\/GSk3\u03b2 pathway in the mouse hippocampus. J Pineal Res 59:47\u201359. https:\/\/doi.org\/10.1111\/jpi.12238","journal-title":"J Pineal Res"},{"key":"4587_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104142","volume":"73","author":"A Wang","year":"2020","unstructured":"Wang A, Xiao C, Zheng J, Ye C, Dai Z, Wu Q, Liu J, Strappe P, Zhou Z (2020) Terpenoids of ganoderma lucidum reverse cognitive impairment through attenuating neurodegeneration via suppression of PI3K\/AKT\/MTOR expression in vivo model. J Funct Foods 73:104142. https:\/\/doi.org\/10.1016\/j.jff.2020.104142","journal-title":"J Funct Foods"},{"key":"4587_CR132","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1074\/jbc.M117.786756","volume":"293","author":"J Gasparotto","year":"2018","unstructured":"Gasparotto J, Girardi CS, Somensi N, Ribeiro CT, Moreira JCF, Michels M, Sonai B, Rocha M, Steckert AV, Barichello T, Quevedo J, Dal-pizzol F, Gelain DP (2018) Cro receptor for advanced glycation end products mediates sepsis-triggered amyloid- \u2424 accumulation, tau phosphoryla- tion, and cognitive impairment. J Biol Chem 293:226\u2013244. https:\/\/doi.org\/10.1074\/jbc.M117.786756","journal-title":"J Biol Chem"},{"key":"4587_CR133","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 21:802\u2013818. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.013","journal-title":"Drug Discov Today"},{"key":"4587_CR134","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/jpd-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ (2020) The association between type 2 diabetes mellitus and Parkinson\u2019s disease. J Parkinson\u2019s Dis 10:775\u2013789. https:\/\/doi.org\/10.3233\/jpd-191900","journal-title":"J Parkinson\u2019s Dis"},{"key":"4587_CR135","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3892\/ijmm.2016.2833","volume":"39","author":"N Nakano","year":"2017","unstructured":"Nakano N, Matsuda S, Ichimura M, Minami A, Ogino M, Murai T, Kitagishi Y (2017) PI3K\/AKT signaling mediated by g protein-coupled receptors is involved in neurodegenerative Parkinson\u2019s disease (review). Int J Mol Med 39:253\u2013260. https:\/\/doi.org\/10.3892\/ijmm.2016.2833","journal-title":"Int J Mol Med"},{"key":"4587_CR136","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JPD-171285","volume":"8","author":"K Annekatrin","year":"2018","unstructured":"Annekatrin K (2018) Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson\u2019s disease. J Parkinsons Dis 8:33\u201343. https:\/\/doi.org\/10.3233\/JPD-171285","journal-title":"J Parkinsons Dis"},{"key":"4587_CR137","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4081\/ejh.2013.e5","volume":"57","author":"G Natale","year":"2013","unstructured":"Natale G, Pompili E, Biagioni F, Paparelli S, Lenzi P, Fornai F (2013) Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases. Eur J Histochem 57:31\u201335. https:\/\/doi.org\/10.4081\/ejh.2013.e5","journal-title":"Eur J Histochem"},{"key":"4587_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1872214810999160628105549","volume":"10","author":"MR Ashraghi","year":"2016","unstructured":"Ashraghi MR, Pagano G, Polychronis S, Niccolini F, Politis M (2016) Parkinson\u2019s disease, diabetes and cognitive impairment. Recent Pat Endocr Metab Immune Drug Discov 10:11\u201321. https:\/\/doi.org\/10.2174\/1872214810999160628105549","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"4587_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17134805","volume":"17","author":"SY Wang","year":"2020","unstructured":"Wang SY, Wu SL, Chen TC, Chuang C. Sen (2020) Antidiabetic agents for treatment of Parkinson\u2019s disease: a meta-analysis. Int J Environ Res Public Health 17:1\u201311. https:\/\/doi.org\/10.3390\/ijerph17134805","journal-title":"Int J Environ Res Public Health"},{"key":"4587_CR140","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2337\/dc08-0479","volume":"31","author":"C Becker","year":"2008","unstructured":"Becker C, Brobert GP, Johansson S, Jick SS, Meier CR (2008) Diabetes in patients with idiopathic Parkinson\u2019s disease. Diabetes Care 31:1808\u20131812. https:\/\/doi.org\/10.2337\/dc08-0479","journal-title":"Diabetes Care"},{"key":"4587_CR141","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/brain\/123.2.340","volume":"123","author":"MTM Hu","year":"2000","unstructured":"Hu MTM, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labb\u00e9 C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ (2000) Cortical dysfunction in non-demented Parkinson\u2019s disease patients. A combined 31P-MRS and 18FDG-PET study. Brain 123:340\u2013352. https:\/\/doi.org\/10.1093\/brain\/123.2.340","journal-title":"Brain"},{"key":"4587_CR142","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jnr.21644","volume":"2082","author":"S Shaikh","year":"2008","unstructured":"Shaikh S, Nicholson LFB (2008) Advanced glycation end products induce in vitro cross-linking of a -synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res 2082:2071\u20132082. https:\/\/doi.org\/10.1002\/jnr.21644","journal-title":"J Neurosci Res"},{"key":"4587_CR143","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.neurobiolaging.2011.12.006","volume":"33","author":"P Teismann","year":"2012","unstructured":"Teismann P, Sathe K, Bierhaus A, Leng L, Martin HL, Bucala R, Weigle B, Nawroth PP, Schulz JB (2012) Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. NBA 33:2478\u20132490. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.12.006","journal-title":"NBA"},{"key":"4587_CR144","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2019.02.014","volume":"135","author":"N Sharma","year":"2019","unstructured":"Sharma N, Pavani S, Kalivendi SV (2019) Free radical biology and medicine the deglycase activity of DJ-1 mitigates \u03b1 -synuclein glycation and aggregation in dopaminergic cells\u202f: role of oxidative stress mediated downregulation of DJ-1 in Parkinson\u2019s disease. Free Radic Biol Med 135:28\u201337. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.02.014","journal-title":"Free Radic Biol Med"},{"key":"4587_CR145","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1074\/jbc.M110.179390","volume":"286","author":"H Murata","year":"2011","unstructured":"Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami JI, Yamada H, Kataoka K, Huh NH (2011) A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK\/PINK1: activation of AKT via MTORC2. J Biol Chem 286:7182\u20137189. https:\/\/doi.org\/10.1074\/jbc.M110.179390","journal-title":"J Biol Chem"},{"key":"4587_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104553","volume":"143","author":"A Gugliandolo","year":"2020","unstructured":"Gugliandolo A, Pollastro F, Bramanti P, Mazzon E (2020) Cannabidiol exerts protective effects in an in vitro model of Parkinson\u2019s disease activating AKT\/MTOR pathway. Fitoterapia 143:104553. https:\/\/doi.org\/10.1016\/j.fitote.2020.104553","journal-title":"Fitoterapia"},{"key":"4587_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-319-60189-2_6","volume":"18","author":"MR Bryan","year":"2017","unstructured":"Bryan MR, Bowman AB (2017) Manganese and the insulin-IGF signaling network in huntington\u2019s disease and other neurodegenerative disorders. Adv Neurobiol 18:113\u2013142. https:\/\/doi.org\/10.1007\/978-3-319-60189-2_6","journal-title":"Adv Neurobiol"},{"key":"4587_CR148","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.93508","author":"N Ersoy Tunal\u0131","year":"2021","unstructured":"Ersoy Tunal\u0131 N (2021) Molecular mechanisms of polyglutamine pathology and lessons learned from Huntington\u2019s disease. Neurodegener Dis. https:\/\/doi.org\/10.5772\/intechopen.93508","journal-title":"Neurodegener Dis"},{"key":"4587_CR149","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin E, R\u00e9gulier E, Perrin V, D\u00fcrr A, Brice A, Aebischer P, D\u00e9glon N, Humbert S, Saudou F (2005) Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21:1478\u20131488. https:\/\/doi.org\/10.1111\/j.1460-9568.2005.03985.x","journal-title":"Eur J Neurosci"},{"key":"4587_CR150","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910889","author":"Y Ehinger","year":"2020","unstructured":"Ehinger Y, Bruy\u00e8re J, Panayotis N, Abada Y, Borloz E, Matagne V, Scaramuzzino C, Vitet H, Delatour B, Saidi L, Villard L, Saudou F, Roux J (2020) Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp 2 knockout mice. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201910889","journal-title":"EMBO Mol Med"},{"key":"4587_CR151","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/hmg\/ddm360","volume":"17","author":"JC Li\u00e9vens","year":"2008","unstructured":"Li\u00e9vens JC, Ich\u00e9 M, Laval M, Faivre-Sarrailh C, Birman S (2008) AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in drosophila models of Huntington\u2019s disease. Hum Mol Genet 17:882\u2013894. https:\/\/doi.org\/10.1093\/hmg\/ddm360","journal-title":"Hum Mol Genet"},{"key":"4587_CR152","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JHD-190366","volume":"8","author":"IC Bras","year":"2019","unstructured":"Bras IC, Konig A (2019) Glycation in Huntington\u2019s disease\u202f: a possible modifier and target for intervention. J Huntingtons Dis 8:245\u2013256. https:\/\/doi.org\/10.3233\/JHD-190366","journal-title":"J Huntingtons Dis"},{"key":"4587_CR153","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10495-019-01520-4.Excess","volume":"176","author":"CT Timothy Hansen","year":"2019","unstructured":"Timothy Hansen CT (2019) Excess active P13K rescues Huntingtin-mediated neuronal cell death but has no effect on axonal transport defects. Apoptosis 176:341\u2013358. https:\/\/doi.org\/10.1007\/s10495-019-01520-4.Excess","journal-title":"Apoptosis"},{"key":"4587_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-019-0456-1","volume":"12","author":"KS Abd-Elrahman","year":"2019","unstructured":"Abd-Elrahman KS, Ferguson SSG (2019) Modulation of MTOR and CREB pathways following MGluR5 blockade contribute to improved Huntington\u2019s pathology in ZQ175 mice. Mol Brain 12:1\u20139. https:\/\/doi.org\/10.1186\/s13041-019-0456-1","journal-title":"Mol Brain"},{"key":"4587_CR155","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","volume":"33","author":"S Saberi","year":"2015","unstructured":"Saberi S, Stauffer JE, Schulte DJ, Ravits J (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin 33:855\u2013876. https:\/\/doi.org\/10.1016\/j.ncl.2015.07.012","journal-title":"Neurol Clin"},{"issue":"1\u20132","key":"4587_CR156","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/17482960902822960","volume":"11","author":"P-F Pradat","year":"2010","unstructured":"Pradat P-F, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte J-M, Jardel C, Coussieu C, Le Forestier N, Lacomblez L, Loeffler J-P, Vincent VM (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1\u20132):166\u2013171","journal-title":"Amyotroph Lateral Scler"},{"key":"4587_CR157","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1789.2001.00359.x","author":"S Kato","year":"2001","unstructured":"Kato S, Nakashima K, Horiuchi S, Nagai R, Cleveland DW, Liu J, Hirano A, Takikawa M, Kato M, Nakano I, Sakoda S, Asayama K, Ohama E (2001) Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human. Neuropathology. https:\/\/doi.org\/10.1046\/j.1440-1789.2001.00359.x","journal-title":"Neuropathology"},{"key":"4587_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2016.00117","volume":"10","author":"JK Juranek","year":"2016","unstructured":"Juranek JK, Daffu GK, Geddis MS, Li H, Rosario R, Kaplan BJ, Kelly L, Schmidt AM (2016) Soluble RAGE treatment delays progression of amyotrophic lateral sclerosis in SOD1 mice. Front Cell Neurosci 10:1\u20139. https:\/\/doi.org\/10.3389\/fncel.2016.00117","journal-title":"Front Cell Neurosci"},{"key":"4587_CR159","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/146608202760196020","volume":"3","author":"S Kikuchi","year":"2002","unstructured":"Kikuchi S, Shinpo K, Ogata A, Tsuji S, Takeuchi M, Makita Z, Tashiro K (2002) Detection of N\u03b5-(Carboxymethyl)Lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotroph Lateral Scler Other Motor Neuron Disord 3:63\u201368. https:\/\/doi.org\/10.1080\/146608202760196020","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"4587_CR160","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2004.08.071","volume":"371","author":"E Kaufmann","year":"2004","unstructured":"Kaufmann E, Boehm BO, S\u00fcssmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, Tumani H (2004) The advanced glycation end-product N \u03b5-(Carboxymethyl)Lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurosci Lett 371:226\u2013229. https:\/\/doi.org\/10.1016\/j.neulet.2004.08.071","journal-title":"Neurosci Lett"},{"key":"4587_CR161","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.mcn.2015.08.009","volume":"68","author":"X Yin","year":"2015","unstructured":"Yin X, Ren M, Jiang H, Cui S, Wang S, Jiang H, Qi Y, Wang J, Wang X, Dong G, Leeds P, Chuang DM, Feng H (2015) Downregulated AEG-1 together with inhibited PI3K\/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol Cell Neurosci 68:303\u2013313. https:\/\/doi.org\/10.1016\/j.mcn.2015.08.009","journal-title":"Mol Cell Neurosci"},{"key":"4587_CR162","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1471-4159.2007.05206.x","volume":"105","author":"L Tolosa","year":"2008","unstructured":"Tolosa L, Mir M, Asensio J, Olmos G (2008) Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem 105:1080\u20131090. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05206.x","journal-title":"J Neurochem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04587-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T14:04:35Z","timestamp":1683381875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04587-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":162,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4587"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04587-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"14 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}